BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 36580877)

  • 1. Comparison of demographics, disease characteristics, and outcomes between Black and White patients with myelodysplastic syndromes: A population-based study.
    Lesegretain A; Brunner A; King AJ; Laadem A; Fell G; Fathi AT
    Leuk Res; 2023 Feb; 125():107006. PubMed ID: 36580877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of race and health care system with disease stage and survival in veterans with larynx cancer.
    Voora RS; Kotha NV; Kumar A; Qiao EM; Qian AS; Panuganti BA; Banegas MP; Weissbrod PA; Stewart TF; Rose BS; Orosco RK
    Cancer; 2021 Aug; 127(15):2705-2713. PubMed ID: 33799314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myelodysplastic syndromes: incidence and survival in the United States.
    Ma X; Does M; Raza A; Mayne ST
    Cancer; 2007 Apr; 109(8):1536-42. PubMed ID: 17345612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of patients with myelodysplastic syndromes in the Veterans Administration population.
    Komrokji RS; Matacia-Murphy GM; Al Ali NH; Beg MS; Safa MM; Rollison DE; List AF
    Leuk Res; 2010 Jan; 34(1):59-62. PubMed ID: 19368972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of race and ethnicity on outcomes of patients with myelodysplastic syndromes: a population-based analysis.
    Goksu SY; Ozer M; Goksu BB; Wang R; Khatib J; Patel PA; Vusirikala M; Cole S; Seyhanli A; Collins RH; Chung S; Zeidan AM; Madanat YF
    Leuk Lymphoma; 2022 Jul; 63(7):1651-1659. PubMed ID: 35133215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the contribution of demographics, access to health care, treatment, and tumor characteristics to racial differences in survival of advanced prostate cancer.
    Krimphove MJ; Cole AP; Fletcher SA; Harmouch SS; Berg S; Lipsitz SR; Sun M; Nabi J; Nguyen PL; Hu JC; Kibel AS; Choueiri TK; Kluth LA; Trinh QD
    Prostate Cancer Prostatic Dis; 2019 Mar; 22(1):125-136. PubMed ID: 30171227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The incidence, risk factors, and survival of acute myeloid leukemia secondary to myelodysplastic syndrome: A population-based study.
    Ye X; Chen D; Zheng Y; Wu C; Zhu X; Huang J
    Hematol Oncol; 2019 Oct; 37(4):438-446. PubMed ID: 31378958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiologic evaluation of clinical outcomes in ethnic minorities with myelodysplastic syndromes.
    Molina A; Xiao L; Ostrom QT; Rosas LG; Greenberg PL
    Leuk Res; 2022 Aug; 119():106907. PubMed ID: 35772318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
    Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease-related costs of care and survival among Medicare-enrolled patients with myelodysplastic syndromes.
    Zeidan AM; Wang R; Davidoff AJ; Ma S; Zhao Y; Gore SD; Gross CP; Ma X
    Cancer; 2016 May; 122(10):1598-607. PubMed ID: 26970288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Cancer Stage and Treatment Differences on Racial Disparities in Survival From Colon Cancer: A United States Population-Based Study.
    Lai Y; Wang C; Civan JM; Palazzo JP; Ye Z; Hyslop T; Lin J; Myers RE; Li B; Jiang B; Sama A; Xing J; Yang H
    Gastroenterology; 2016 May; 150(5):1135-1146. PubMed ID: 26836586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial disparities in overall survival among renal cell carcinoma patients with young age and small tumors.
    Schwartz K; Ruterbusch JJ; Colt JS; Miller DC; Chow WH; Purdue MP
    Cancer Med; 2016 Feb; 5(2):200-8. PubMed ID: 26710924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Effectiveness of Biologic Agents Among Black and White Medicare Patients in the US With Metastatic Colorectal Cancer.
    Goel S; Negassa A; Acuna-Villaorduna A
    JAMA Netw Open; 2021 Dec; 4(12):e2136378. PubMed ID: 34910154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and survival estimates for patients with myelodysplastic syndrome in the early 21st century: no evidence of improvement over time.
    Pulte D; Jansen L; Brenner H
    Leuk Lymphoma; 2022 Aug; 63(8):1964-1969. PubMed ID: 35343360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A population-based study of survival in patients with secondary myelodysplastic syndromes (MDS): impact of type and treatment of primary cancers.
    De Roos AJ; Deeg HJ; Davis S
    Cancer Causes Control; 2007 Dec; 18(10):1199-208. PubMed ID: 17823848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in incidence, initial treatment and survival of myelodysplastic syndromes: a population-based study of 5144 patients diagnosed in the Netherlands from 2001 to 2010.
    Dinmohamed AG; Visser O; van Norden Y; Huijgens PC; Sonneveld P; van de Loosdrecht AA; Jongen-Lavrencic M
    Eur J Cancer; 2014 Mar; 50(5):1004-12. PubMed ID: 24388662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comorbidities and malignancies negatively affect survival in myelodysplastic syndromes: a population-based study.
    Rozema J; Hoogendoorn M; Kibbelaar R; van den Berg E; Veeger N; van Roon E
    Blood Adv; 2021 Mar; 5(5):1344-1351. PubMed ID: 33656535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma.
    Mathur AK; Osborne NH; Lynch RJ; Ghaferi AA; Dimick JB; Sonnenday CJ
    Arch Surg; 2010 Dec; 145(12):1158-63. PubMed ID: 21173289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential Outcomes Among Survivors of Head and Neck Cancer Belonging to Racial and Ethnic Minority Groups.
    Taylor DB; Osazuwa-Peters OL; Okafor SI; Boakye EA; Kuziez D; Perera C; Simpson MC; Barnes JM; Bulbul MG; Cannon TY; Watts TL; Megwalu UC; Varvares MA; Osazuwa-Peters N
    JAMA Otolaryngol Head Neck Surg; 2022 Feb; 148(2):119-127. PubMed ID: 34940784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disparities among racial/ethnic groups of patients diagnosed with ependymoma: analyses from the Surveillance, Epidemiology and End Results (SEER) registry.
    Stenzel AE; Fenstermaker RA; Wiltsie LM; Moysich KB
    J Neurooncol; 2019 Aug; 144(1):43-51. PubMed ID: 31209774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.